BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15947537)

  • 1. Importance of in-hospital initiation of evidence-based medical therapies for heart failure: taking advantage of the teachable moment.
    Fonorow GC
    Congest Heart Fail; 2005; 11(3):153-4. PubMed ID: 15947537
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-based therapy for heart failure.
    Deedwania PC; Carbajal E
    Med Clin North Am; 2012 Sep; 96(5):915-31. PubMed ID: 22980055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL; Ahmed A
    J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract]   [Full Text] [Related]  

  • 4. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
    Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T; Takeshita A
    Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing patients with heart failure: the reality of clinical practice.
    Squire I
    Eur Heart J; 2005 Dec; 26(24):2611-3. PubMed ID: 16219652
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slowing the progression of heart failure.
    Cohn JN
    Eur Heart J; 1996 Nov; 17(11):1609-11. PubMed ID: 8922902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neurohumoral blocking agents].
    Kurisu S; Kihara Y
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():394-6. PubMed ID: 22724235
    [No Abstract]   [Full Text] [Related]  

  • 10. Suggestions to improve the quality of life in heart failure.
    Thulasimani M; Ramaswamy M
    Eur Heart J; 2003 Sep; 24(18):1700. PubMed ID: 14499236
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
    Porcu M
    Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
    Buckberg GD;
    Heart Fail Rev; 2004 Oct; 9(4):347-51. PubMed ID: 15886980
    [No Abstract]   [Full Text] [Related]  

  • 13. MY APPROACH to the patient with heart failure and improved ejection fraction
    Cohn JN
    Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
    [No Abstract]   [Full Text] [Related]  

  • 14. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I; Liu P; Webb G
    Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart failure - up to date].
    Müller-Edenborn B; Eriksson U
    Praxis (Bern 1994); 2013 Aug; 102(17):1053-60. PubMed ID: 23965718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness.
    Shekelle P; Morton S; Atkinson S; Suttorp M; Tu W; Heidenreich P; Gubens M; Maglione M; Jungvig L; Roth E; Newberry S
    Evid Rep Technol Assess (Summ); 2003 Jul; (82):1-6. PubMed ID: 14571595
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on pharmacological advances.
    Fonarow G
    J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
    [No Abstract]   [Full Text] [Related]  

  • 18. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):157-60. PubMed ID: 15030275
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diastolic cardiac insufficiency].
    Spoto S; Palma Modoni A; De Galasso L
    Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
    [No Abstract]   [Full Text] [Related]  

  • 20. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
    Remme WJ
    Heart Fail Clin; 2005 Apr; 1(1):67-75. PubMed ID: 17386835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.